Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-26T09:45:17.045Z Has data issue: false hasContentIssue false
  • English
  • Français

Ethical Issues Raised by Needle Exchange Programs

Published online by Cambridge University Press:  01 January 2021

Sana Loue ,
Peter Lurie  and
Linda S. Lloyd
Get access Rights & Permissions [Opens in a new window]

Extract

United States public health experts have long expressed concern about the prevalence of the human immunodeficiency virus (HIV) among injection drug users (IDUs). The United States has the largest reported IDU population in the world: 1.1 to 1.5 million. Recent estimates from the Centers for Disease Control and Prevention (CDC) suggest that 50 percent of incident HIV infections occur among IDUs, with additional infections occurring among their sex partners and offspring. More than 33 percent of new AIDS cases occur in IDUs, their sexual partners, and their children. Almost one half of all women diagnosed with AIDS in the United States are IDUS. Many of the remaining infected women were infected as a result of sex with a male IDU.

While public health agencies, legislators, community leaders, and religious groups have engaged in vigorous debate over the merits of needle exchange programs (NEPs) as an intervention to reduce HIV transmission, the programs, some legal and some illegal, have been implemented in fifty-five cities across the country.

Type
Article
Information
Journal of Law, Medicine & Ethics , Volume 23 , Issue 4 , Winter 1995 , pp. 382 - 388
Copyright
Copyright © American Society of Law, Medicine and Ethics 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Dondero, T., “Human Immunodeficiency Virus Infection in the United States: A Review of Current Knowledge,” Morbidity and Mortality Weekly Report, 36 (1987): 125–74; and Turner, S. Miller, H. Moses, L., AIDS: Sexual Behavior And Intravenous Drug Use (Washington, D.C.: National Academy Press, 1989).Google Scholar
Kolata, G., “New Picture of Who Will Get AIDS is Crammed with Addicts,” New York Times, Feb. 28, 1995, at B6.Google Scholar
Centers for Disease Control and Prevention, Facts About Drug Use and HIV/AIDS (Atlanta: CDC, Sept. 1993); and Centers for Disease Control and Prevention, Facts About Women and HIV/AIDS (Atlanta: CDC, Oct. 1993).Google Scholar
Anon, NASEN Newsworks (Tacoma: North American Syringe Exchange Network, Dec. 16, 1994): At 1.Google Scholar
Sorge, R., “Harm Reduction: A New Approach to Drug Services,” Health/PAC Bulletin, Winter (1991): 22–27; and Des Jarlais, D.C. et al., “International Epidemiology of HIV and AIDS among Injecting Drug Users,” AIDS, 6 (1992): 1053–68.Google Scholar
Lurie, P. et al., The Public Health Impact of Needle Exchange Programs in the United States and Abroad (Atlanta: CDC, Vols. 1 & 2, Oct. 1993).Google Scholar
Guydish, J. et al., “Evaluating Needle Exchange: Are There Negative Effects?,” AIDS, 7 (1993): 871–76.CrossRefGoogle Scholar
Hartgers, C. et al., “The Impact of the Needle and Syringe-Exchange Programme in Amsterdam on Injecting Risk Behaviour,” AIDS, 3 (1989): 571–76; Hagan, H. et al., “Lower HIV Seroprevalence, Declining HBV and Safer Injection in Relation to the Tacoma Needle Exchange,” in Final Program and Abstracts of the VII International Conference on AIDS (Florence, Abstract WC 3291, 1991); Watters, J. Cheng, Y., “Syringe Exchange in San Francisco: Preliminary Findings,” in Final Program and Abstracts of the VII International Conference on AIDS (Florence, Abstract ThC99, 1991); Guydish, J. et al., “Sharing Needles: Risk Reduction among Intravenous Drug Users in San Francisco,” in Final Program and Abstracts of the V International Conference on AIDS (Montreal, Abstract ThDP34, 1989); Feldman, H. et al., “Modification of Needle Use in Out-of-Treatment Intravenous Drug Users,” in Final Program and Abstracts of the V International Conference on AIDS (Montreal, Abstract ThDP62, 1989); and Paone, D. et al., “AIDS Risk Reduction Behaviors among Participants of Needle Syringe Exchange Programs in New York City, USA,” in Final Program and Abstracts of the IX International Conference on AIDS (Berlin, Abstract PO-C24-3188, 1993).Google Scholar
Oliver, K.J. et al., Letter, “Impact of a Needle Exchange Program on Potentially Infectious Syringes in Public Places,” Journal of Acquired Immune Deficiency Syndromes, 5 (1992): 534.CrossRefGoogle Scholar
Des Jarlais, D.C. Friedman, S.R., “AIDS and Legal Access to Sterile Drug Injection Equipment,” Annals of the American Academy of Political and Social Science, 521 (1992): 42–65; and Lurie, et al., supra note 6.CrossRefGoogle Scholar
Paone, D. et al., “New York City Syringe Exchange: Expansion, Risk Reduction, and Seroincidence,” Abstract PC0470 presented at X International Conference on AIDS, Yokohama, Aug. 7–12, 1994.Google Scholar
Kaplan, E.H. Heimer, R., “A Circulation Theory of Needle Exchange,” AIDS, 8 (1994): 567–74.CrossRefGoogle Scholar
Beauchamp, T.L. Childress, J.F., Principles of Biomedical Ethics (New York: Oxford University Press, 4th ed., 1994).Google Scholar
Lurie, et al., supra note 6.Google Scholar
Oliver, et al., supra note 9; and Lurie, et al., supra note 6.Google Scholar
Lurie, et al., supra note 6.Google Scholar
Id.Google Scholar
Wiley, J. Samuel, M., “Prevalence of HIV Infection in the USA,” AIDS, 3 (1989): 71–78.CrossRefGoogle Scholar
Bennett, C.L. et al “Medical Care Costs of Intravenous Drug Users with AIDS in Brooklyn,” Journal of Acquired Immune Deficiency Syndromes, 5 (1992): 1–6.Google Scholar
County of San Diego, Report, “Exchange as a Means of Reducing the Transmission of HIV Infection,” July 1992, at 1.Google Scholar
Oliver, et al., supra note 9.Google Scholar
Hagan, H. et al., “The Tacoma Syringe Exchange,” Journal of Addictive Diseases, 10 (1991): 81–88; and Kaplan, E. O'Keefe, E. Heimer, R., “Evaluating the New Haven Needle Exchange Program (NEP),” in Final Program and Abstracts of the VII International Conference on AIDS (Florence, Abstract WC 3286, 1991).Google Scholar
Lurie, et al., supra note 6.Google Scholar
Id.; and Kahn, J.G. et al., Updated Estimates of the Impact and Cost of HIV Prevention in Injecting Drug Users (San Francisco: Institute for Health Policy Studies, University of California, 1992).Google Scholar
Sherr, L., “Fear Arousal and AIDS: Do Shock Tactics Work?,” AIDS, 4 (1990): 361–64.CrossRefGoogle Scholar
Lurie, et al., supra note 6; and Donoghoe, M. Dolan, K. Stimson, G., “Changes in Injectors' HIV Risk Behavior and Syringe Supply in UK 1987–90,” in Final Program and Abstracts of the VII International Conference on AIDS (Florence, Abstract ThC45, 1991).Google Scholar
Jarlais, Des et al., supra note 5.Google Scholar
See supra note 21.Google Scholar
Wiley, Samuel, , supra note 18; and Daniels, N., Just Health Care (New York: Cambridge University Press, 1985).Google Scholar
Norman, C., “Transgendered People,” presented at the Seventh National AIDS Update Conference, San Francisco, Feb. 1995.Google Scholar
Gostin, L., “The Interconnected Epidemics of Drug Dependency and AIDS,” Harvard Civil Rights-Civil Liberties Law Review, 26 (1991): 113–84.Google Scholar
Anon, , A Report on HIV/AIDS Activities in Australia 1990–1991 (Canberra: IGCA, 1991).Google Scholar
Keys Young, M.S.J., Fitpacks Evaluation Study (New South Wales: AIDS Bureau, New South Wales Health Dept., Mar. 1992).Google Scholar
Lungley, S. Baker, M., The Needle and Syringe Exchange Scheme in Operation (Wellington: New Zealand Dept. of Health, 1990).Google Scholar
Anon, Needle Exchange Programs: Research Suggests Promise as an AIDS Prevention Strategy (Washington, D.C.: General Accounting Office, Mar. 1993).Google Scholar
Theisen, R., “Legal Climate for Increased Needle and Syringe Availability,” presentation at Needle and Syringe Availability and Exchange for HIV Prevention, Kaiser Family Foundation, Menlo Park, Dec. 10–11, 1992.Google Scholar
Freedman, B., “Equipoise and the Ethics of Clinical Research,” N. Engl. J. Med., 317 (1987): 141–45.CrossRefGoogle Scholar
National Research Council, AIDS: Sexual Behavior and Intravenous Drug Use (Washington D.C.: National Academy Press, 1992); National Research Council, AIDS: The Second Decade (Washington, D.C.: National Academy Press, 1990); and Institute of Medicine, AIDS and Behavior: An Integrated Approach (Washington, D.C.: National Academy Press, 1994).Google Scholar
President's Commission on Acquired Immune Deficiency Syndrome, The Twin Epidemics of Substance Abuse and HIV (Washington, D.C.: President's Commission on Acquired Immune Deficiency Syndrome, July 1991).Google Scholar
Anon, supra note 35.Google Scholar
Lurie, et al., supra note 6.Google Scholar
Anon, The Clinton Administration's Internal Reviews of Research on Needle Exchange Programs (Washington, D.C.: Drug Policy Foundation, Mar. 7, 1995).Google Scholar
Lugoboni, F. et al., “An HBV Vaccination Program for Street Injecting Drug Users: Implications for Testing an HIV Vaccine,” poster PoC 4796 presented at VIII International Conference on AIDS, Amsterdam, July 19–24, 1992.Google Scholar